National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Niciu, M. J., Meisner, R. C., Carr, B. R., Farooqui, A. A., Feifel, D., Kaplin, A., … Parikh, S. V. (2024, February 1). National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder. Journal of Affective Disorders. Elsevier B.V. https://doi.org/10.1016/j.jad.2023.11.008